Atezolizumab Plus Bevacizumab Alone or Combined With External Beam Radiotherapy for HCC With Macrovascular Invasion
Conditions:  Hepatocellular Carcinoma;  Hepatocellular Cancer;  Hepatocellular Carcinoma Non-resectable;  Hepatocellular Carcinoma Stage IV;  Liver Cancer Interventions:  Radiation: Atezolizumab plus bevacizumab, combined EBRT to vascular invasion;  Drug: Atezolizumab plus bevacizumab Sponsors:  Asan Medical Center;  Seoul National University Hospital;  Hanyang University;  Soon Chun Hyang University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Cancer | Cancer & Oncology | Carcinoma | External Beam Therapy | Hospitals | Research